Advances in Molecular Oncology [electronic resource] : Edited under the auspices of the European Institute of Oncology (IEO) and The FIRC Institute of Molecular Oncology Foundation (IFOM) / edited by Fabrizio d'Adda di Fagagna, Susanna Chiocca, Fraser McBlane, Ugo Cavallaro.

Genome Instability, Checkpoints, and the Cell Cycle -- Comparison of DNA Replication in Xenopus laevis and Simian Virus 40 -- A Genetic Screen Implicates miRNA-372 and miRNA-373 as Oncogenes in Testicular Germ Cell Tumors -- An Investigation into 53BP1 Complex Formation -- Short Abstracts Session I -- Tumor and Microenvironment Interactions -- Tumor Promotion by Tumor-Associated Macrophages -- The AP-2a Transcription Factor Regulates Tumor Cell Migration and Apoptosis -- Modulatory Actions of Neuropeptide Y on Prostate Cancer Growth: Role of MAP Kinase/ERK 1/2 Activatio -- Short Abstracts Session II -- Animal Models -- The Arf Tumor Suppressor in Acute Leukemias: Insights from Mouse Models of BcrAbl-Induced Acute Lymphoblastic Leukemia -- Short Abstracts Session III -- Transcription and Epigenetics -- Short Abstracts Session IV -- High-Throughput Approaches and Imaging -- Identification and Validation of the Anaplastic Large Cell Lymphoma Signature -- Cell-Cycle Inhibitor Profiling by High-Content Analysis -- Short Abstracts Session V -- Novel Pathways and Therapeutic Targets -- Regulation for Nuclear Targeting of the Abl Tyrosine Kinase in Response to DNA Damage -- Short Abstracts Session VI -- Poster Abstracts -- Poster Abstracts.

Proceedings of the 2nd Annual IFOM-IEO Meeting on Cancer. This is a new meeting, it has about 200 attendees from Australia, Austria, Belgium, Brazil, Canada, England, France, Germany, Greece, Ireland, Italy, Japan, Netherlands, Spain, Sweden, Switzerland, and the USA. The 2nd IFOM-IEO international meeting on cancer will provide a forum in which the worlds leading cancer researchers and young scientists will discuss the latest advances in molecular oncology. The impact of recent breakthroughs in basic research and of emerging technologies on molecular medicine in cancer will be highlighted.

ZDB-2-SBL